DAVITA HEALTHCARE STUDY GUIDE
2025/2026 | COMPLETE PRACTICE
QUESTIONS & VERIFIED ANSWERS WITH
DETAILED RATIONALES | COMPREHENSIVE
DIALYSIS & CLINICAL TRAINING EXAM PREP
DAVITA HEALTHCARE STUDY GUIDE 2025/2026 | COMPLETE PRACTICE
QUESTIONS & VERIFIED ANSWERS WITH DETAILED RATIONALES |
COMPREHENSIVE DIALYSIS & CLINICAL TRAINING EXAM PREP
DOCUMENT OVERVIEW
• This comprehensive study guide contains practice questions designed to prepare
you for DaVita Healthcare clinical and dialysis technician certification exams, with
verified answers and detailed rationales covering all essential clinical competencies.
• Study approach: Review each question carefully, attempt to answer before
reviewing the correct answer, then read the rationale thoroughly to reinforce your
understanding of key concepts and clinical applications.
PRACTICE QUESTIONS
1. A 62-year-old patient presents to the dialysis center with a blood pressure
reading of 180/95 mmHg. The patient reports a weight gain of 2.5 kg since the
previous session. What is the primary cause of this hypertension in a dialysis
patient?
A) Anemia secondary to chronic kidney disease
B) Fluid overload and sodium retention
C) Hyperkalemia
D) Hypercalcemia
E) Uremic toxins
,CORRECT ANSWER: B) Fluid overload and sodium retention
RATIONALE: In dialysis patients, hypertension is most commonly caused by fluid
overload and sodium retention. The kidneys can no longer regulate fluid and
electrolyte balance adequately, leading to increased intravascular volume. The
weight gain of 2.5 kg since the last session indicates fluid accumulation. Fluid
overload increases cardiac preload, which results in elevated blood pressure. While
anemia, hyperkalemia, and hypercalcemia can contribute to complications in
dialysis patients, they are not the primary drivers of acute hypertension. Uremic
toxins may cause hypertension over time but are not the immediate cause of the
acute presentation.
2. Which vascular access site provides the best long-term patency and lowest
infection rates for hemodialysis patients?
A) Temporary central venous catheter
B) Peripheral venous catheter
C) Arteriovenous fistula (AVF)
D) Arteriovenous graft (AVG)
E) Femoral vein catheter
CORRECT ANSWER: C) Arteriovenous fistula (AVF)
RATIONALE: The arteriovenous fistula is the gold standard vascular access for
hemodialysis. AVFs have superior long-term patency rates (60-70% at 5 years) and
the lowest infection rates compared to other access types. The direct anastomosis
between an artery and vein promotes arterial blood flow through the vein, creating
vessel maturation and durability. AVFs require 4-8 weeks of maturation before use
and are typically created in the forearm or upper arm. In contrast, temporary
catheters have high infection and clotting rates, grafts have intermediate outcomes,
and femoral access is associated with significant complications and is typically used
only as a temporary measure.
,3. A patient on hemodialysis has a serum potassium level of 6.8 mEq/L. What
is the most immediate concern associated with this level?
A) Hypocalcemia
B) Cardiac arrhythmias
C) Hypokalemia
D) Metabolic acidosis
E) Bone disease
CORRECT ANSWER: B) Cardiac arrhythmias
RATIONALE: Hyperkalemia (serum potassium >6.5 mEq/L) poses a life-threatening
risk of cardiac arrhythmias. Elevated potassium levels affect the electrical
conduction system of the heart, potentially causing peaked T waves on ECG,
prolonged PR intervals, and widened QRS complexes. Severe hyperkalemia can
precipitate ventricular fibrillation or asystole. This is a medical emergency requiring
immediate intervention such as calcium gluconate (cardiac membrane stabilizer),
insulin with dextrose, sodium bicarbonate, or urgent dialysis. The normal serum
potassium range is 3.5-5.0 mEq/L. While other complications exist with
hyperkalemia, cardiac arrhythmias present the most immediate life-threatening
risk.
4. During a hemodialysis session, you notice the venous pressure line
gradually increasing from 4 mmHg to 12 mmHg. What is the most likely
cause?
A) Arterial needle displacement
B) Clotting in the vascular access
C) Excessive ultrafiltration
D) Dialysate temperature too high
E) Arterial stenosis
CORRECT ANSWER: B) Clotting in the vascular access
, RATIONALE: Rising venous pressure during dialysis typically indicates an
obstruction to blood flow on the venous side of the circuit. This most commonly
results from clotting in the vascular access, venous needle, or tubing. As the clot
forms, resistance increases, requiring higher venous pressure to return blood.
Normal venous pressure ranges from 2-8 mmHg. An increase to 12 mmHg signals a
developing problem that requires immediate intervention to prevent complete
access thrombosis. Arterial needle displacement would cause low venous
pressures, not elevated ones. Excessive ultrafiltration affects patient
hemodynamics but not necessarily venous line pressures. Dialysate temperature
and arterial stenosis would not cause progressive venous pressure increases in this
pattern.
5. A patient with diabetic nephropathy is beginning hemodialysis. Which
laboratory abnormality is most common in this population at the initiation of
dialysis?
A) Hypercalcemia
B) Hyperphosphatemia
C) Hypokalemia
D) Hypoglycemia
E) Hypoalbuminemia
CORRECT ANSWER: B) Hyperphosphatemia
RATIONALE: Hyperphosphatemia is one of the most prevalent electrolyte
abnormalities in patients with end-stage renal disease (ESRD) and diabetic
nephropathy. As kidney function declines, the ability to excrete phosphate
diminishes, leading to elevated serum phosphate levels (normal: 2.5-4.5 mg/dL).
Phosphate retention triggers secondary hyperparathyroidism, which accelerates
mineral bone disease. Diabetic patients may have additional factors including
dietary intake and poor medication adherence. Hyperphosphatemia can be
managed through dietary phosphate restriction, use of phosphate binders (calcium
acetate, sevelamer), and adequate dialysis. While other electrolyte abnormalities
2025/2026 | COMPLETE PRACTICE
QUESTIONS & VERIFIED ANSWERS WITH
DETAILED RATIONALES | COMPREHENSIVE
DIALYSIS & CLINICAL TRAINING EXAM PREP
DAVITA HEALTHCARE STUDY GUIDE 2025/2026 | COMPLETE PRACTICE
QUESTIONS & VERIFIED ANSWERS WITH DETAILED RATIONALES |
COMPREHENSIVE DIALYSIS & CLINICAL TRAINING EXAM PREP
DOCUMENT OVERVIEW
• This comprehensive study guide contains practice questions designed to prepare
you for DaVita Healthcare clinical and dialysis technician certification exams, with
verified answers and detailed rationales covering all essential clinical competencies.
• Study approach: Review each question carefully, attempt to answer before
reviewing the correct answer, then read the rationale thoroughly to reinforce your
understanding of key concepts and clinical applications.
PRACTICE QUESTIONS
1. A 62-year-old patient presents to the dialysis center with a blood pressure
reading of 180/95 mmHg. The patient reports a weight gain of 2.5 kg since the
previous session. What is the primary cause of this hypertension in a dialysis
patient?
A) Anemia secondary to chronic kidney disease
B) Fluid overload and sodium retention
C) Hyperkalemia
D) Hypercalcemia
E) Uremic toxins
,CORRECT ANSWER: B) Fluid overload and sodium retention
RATIONALE: In dialysis patients, hypertension is most commonly caused by fluid
overload and sodium retention. The kidneys can no longer regulate fluid and
electrolyte balance adequately, leading to increased intravascular volume. The
weight gain of 2.5 kg since the last session indicates fluid accumulation. Fluid
overload increases cardiac preload, which results in elevated blood pressure. While
anemia, hyperkalemia, and hypercalcemia can contribute to complications in
dialysis patients, they are not the primary drivers of acute hypertension. Uremic
toxins may cause hypertension over time but are not the immediate cause of the
acute presentation.
2. Which vascular access site provides the best long-term patency and lowest
infection rates for hemodialysis patients?
A) Temporary central venous catheter
B) Peripheral venous catheter
C) Arteriovenous fistula (AVF)
D) Arteriovenous graft (AVG)
E) Femoral vein catheter
CORRECT ANSWER: C) Arteriovenous fistula (AVF)
RATIONALE: The arteriovenous fistula is the gold standard vascular access for
hemodialysis. AVFs have superior long-term patency rates (60-70% at 5 years) and
the lowest infection rates compared to other access types. The direct anastomosis
between an artery and vein promotes arterial blood flow through the vein, creating
vessel maturation and durability. AVFs require 4-8 weeks of maturation before use
and are typically created in the forearm or upper arm. In contrast, temporary
catheters have high infection and clotting rates, grafts have intermediate outcomes,
and femoral access is associated with significant complications and is typically used
only as a temporary measure.
,3. A patient on hemodialysis has a serum potassium level of 6.8 mEq/L. What
is the most immediate concern associated with this level?
A) Hypocalcemia
B) Cardiac arrhythmias
C) Hypokalemia
D) Metabolic acidosis
E) Bone disease
CORRECT ANSWER: B) Cardiac arrhythmias
RATIONALE: Hyperkalemia (serum potassium >6.5 mEq/L) poses a life-threatening
risk of cardiac arrhythmias. Elevated potassium levels affect the electrical
conduction system of the heart, potentially causing peaked T waves on ECG,
prolonged PR intervals, and widened QRS complexes. Severe hyperkalemia can
precipitate ventricular fibrillation or asystole. This is a medical emergency requiring
immediate intervention such as calcium gluconate (cardiac membrane stabilizer),
insulin with dextrose, sodium bicarbonate, or urgent dialysis. The normal serum
potassium range is 3.5-5.0 mEq/L. While other complications exist with
hyperkalemia, cardiac arrhythmias present the most immediate life-threatening
risk.
4. During a hemodialysis session, you notice the venous pressure line
gradually increasing from 4 mmHg to 12 mmHg. What is the most likely
cause?
A) Arterial needle displacement
B) Clotting in the vascular access
C) Excessive ultrafiltration
D) Dialysate temperature too high
E) Arterial stenosis
CORRECT ANSWER: B) Clotting in the vascular access
, RATIONALE: Rising venous pressure during dialysis typically indicates an
obstruction to blood flow on the venous side of the circuit. This most commonly
results from clotting in the vascular access, venous needle, or tubing. As the clot
forms, resistance increases, requiring higher venous pressure to return blood.
Normal venous pressure ranges from 2-8 mmHg. An increase to 12 mmHg signals a
developing problem that requires immediate intervention to prevent complete
access thrombosis. Arterial needle displacement would cause low venous
pressures, not elevated ones. Excessive ultrafiltration affects patient
hemodynamics but not necessarily venous line pressures. Dialysate temperature
and arterial stenosis would not cause progressive venous pressure increases in this
pattern.
5. A patient with diabetic nephropathy is beginning hemodialysis. Which
laboratory abnormality is most common in this population at the initiation of
dialysis?
A) Hypercalcemia
B) Hyperphosphatemia
C) Hypokalemia
D) Hypoglycemia
E) Hypoalbuminemia
CORRECT ANSWER: B) Hyperphosphatemia
RATIONALE: Hyperphosphatemia is one of the most prevalent electrolyte
abnormalities in patients with end-stage renal disease (ESRD) and diabetic
nephropathy. As kidney function declines, the ability to excrete phosphate
diminishes, leading to elevated serum phosphate levels (normal: 2.5-4.5 mg/dL).
Phosphate retention triggers secondary hyperparathyroidism, which accelerates
mineral bone disease. Diabetic patients may have additional factors including
dietary intake and poor medication adherence. Hyperphosphatemia can be
managed through dietary phosphate restriction, use of phosphate binders (calcium
acetate, sevelamer), and adequate dialysis. While other electrolyte abnormalities
